ÂÜÀòÂÒÂ×

Erin Connolly-Strong has extensive work experience in the medical field, primarily in medical affairs and medical science liaison roles. Erin is currently working as the Chief Medical Science Officer at Genome Insight Inc. since September 2022. Prior to this, Erin held the position of Head of Medical Affairs at Scipher Medicine from August 2020 to April 2022.

Before joining Scipher Medicine, Erin spent a significant portion of their career at Mallinckrodt Pharmaceuticals. Erin held various positions during their tenure, including Senior Director Field Medical Affairs, Autoimmune and Rare Disease Division from April 2017 to August 2020, and Medical Director Rheumatology from April 2018 to January 2020. Earlier in their career at Mallinckrodt Pharmaceuticals, Erin served as the MSL Director for Pulmonology, Rheumatology, and Ophthalmology, as well as the Regional Manager for Rheumatology-Medical Science Liaisons.

Before joining Mallinckrodt Pharmaceuticals, Erin worked as a Medical Science Liaison at Human Genome Sciences from January 2012 to October 2012. Prior to that, they gained research experience as a Postdoctoral Fellow at UCSF from July 2009 to January 2012.

Overall, Erin Connolly-Strong has a strong background in medical affairs, medical science liaison, and research, with expertise in areas such as autoimmune and rare diseases.

Erin Connolly-Strong completed their Bachelor of Science (BS) degree in Biology at Union College from 1998 to 2002. Erin then pursued their Master of Science (MS) degree and Doctor of Philosophy (PhD) degree in Biomedical Science at Albert Einstein College of Medicine, from 2004 to 2006 and 2004 to 2009, respectively. In 2011, Erin enrolled at the Norton Training Institute to complete a Doctor of Philosophy (PhD) in Clinical Research Associate Program. The end year of their studies at Norton Training Institute is not specified.